Literature DB >> 21312196

A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity.

Fang Zhang1, Gar Yee Koh, Duane P Jeansonne, Javoris Hollingsworth, Paul S Russo, Graca Vicente, Rhett W Stout, Zhijun Liu.   

Abstract

Curcumin (CUR) is an active food compound, but its insolubility and instability in water contributes to low bioavailability. In this study, the solubility of CUR was enhanced by utilizing the solubilizing properties of rubusoside (RUB). The solubility of CUR in water increased linearly from 61 μg/mL to 2.318 mg/mL in the presence of RUB ranging from 1% to 10% (w/v). Dynamic light scattering and transmission electron microscopy studies found that CUR and RUB formed CUR-RUB nanoparticle (∼8 nm) complexes. The RUB-solubilized CUR was stable in physiological conditions and did not precipitate when diluted or degrade when spray-dried to a completely reconstitutable powder. Furthermore, cell viability assays demonstrated the efficacy of RUB-solubilized CUR against human colon, breast, and pancreatic cancer cell lines. The development of this new solubilized, stable, and biologically active CUR formulation lays the foundation for future bioavailability improvement.
Copyright © 2011 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21312196     DOI: 10.1002/jps.22512

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  20 in total

Review 1.  Curcumin nanoformulations: a future nanomedicine for cancer.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

2.  Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.

Authors:  Sachin K Khiste; Zhijun Liu; Kartik R Roy; Mohammad B Uddin; Salman B Hosain; Xin Gu; Sami Nazzal; Ronald A Hill; Yong-Yu Liu
Journal:  Mol Cancer Ther       Date:  2019-10-23       Impact factor: 6.261

Review 3.  Epigenetic diet: impact on the epigenome and cancer.

Authors:  Tabitha M Hardy; Trygve O Tollefsbol
Journal:  Epigenomics       Date:  2011-08       Impact factor: 4.778

Review 4.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

5.  Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment.

Authors:  Murali M Yallapu; Mara C Ebeling; Sheema Khan; Vasudha Sundram; Neeraj Chauhan; Brij K Gupta; Susan E Puumala; Meena Jaggi; Subhash C Chauhan
Journal:  Mol Cancer Ther       Date:  2013-05-23       Impact factor: 6.261

6.  Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin.

Authors:  Rulei Yang; Suai Zhang; Deling Kong; Xuli Gao; Yanjun Zhao; Zheng Wang
Journal:  Pharm Res       Date:  2012-08-15       Impact factor: 4.200

7.  Cytotoxic and antiangiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticles.

Authors:  Zhijun Liu; Fang Zhang; Gar Yee Koh; Xin Dong; Javoris Hollingsworth; Jian Zhang; Paul S Russo; Peiying Yang; Rhett W Stout
Journal:  Anticancer Drugs       Date:  2015-02       Impact factor: 2.248

8.  Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer.

Authors:  Anastasios Dimou; Konstantinos N Syrigos; Muhammad Wasif Saif
Journal:  Ther Adv Med Oncol       Date:  2012-09       Impact factor: 8.168

Review 9.  Polymeric micelles: nanocarriers for cancer-targeted drug delivery.

Authors:  Yifei Zhang; Yixian Huang; Song Li
Journal:  AAPS PharmSciTech       Date:  2014-04-04       Impact factor: 3.246

Review 10.  Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.